These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 28086916)

  • 1. Microglial activation in Parkinson's disease using [
    Ghadery C; Koshimori Y; Coakeley S; Harris M; Rusjan P; Kim J; Houle S; Strafella AP
    J Neuroinflammation; 2017 Jan; 14(1):8. PubMed ID: 28086916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging Striatal Microglial Activation in Patients with Parkinson's Disease.
    Koshimori Y; Ko JH; Mizrahi R; Rusjan P; Mabrouk R; Jacobs MF; Christopher L; Hamani C; Lang AE; Wilson AA; Houle S; Strafella AP
    PLoS One; 2015; 10(9):e0138721. PubMed ID: 26381267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroinflammation in healthy aging: a PET study using a novel Translocator Protein 18kDa (TSPO) radioligand, [(18)F]-FEPPA.
    Suridjan I; Rusjan PM; Voineskos AN; Selvanathan T; Setiawan E; Strafella AP; Wilson AA; Meyer JH; Houle S; Mizrahi R
    Neuroimage; 2014 Jan; 84():868-75. PubMed ID: 24064066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative imaging of neuroinflammation in human white matter: a positron emission tomography study with translocator protein 18 kDa radioligand, [18F]-FEPPA.
    Suridjan I; Rusjan PM; Kenk M; Verhoeff NP; Voineskos AN; Rotenberg D; Wilson AA; Meyer JH; Houle S; Mizrahi R
    Synapse; 2014 Nov; 68(11):536-47. PubMed ID: 25043159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translocator protein (18 kDa) polymorphism (rs6971) explains in-vivo brain binding affinity of the PET radioligand [(18)F]-FEPPA.
    Mizrahi R; Rusjan PM; Kennedy J; Pollock B; Mulsant B; Suridjan I; De Luca V; Wilson AA; Houle S
    J Cereb Blood Flow Metab; 2012 Jun; 32(6):968-72. PubMed ID: 22472607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microglia imaging in methamphetamine use disorder: a positron emission tomography study with the 18 kDa translocator protein radioligand [F-18]FEPPA.
    Rathitharan G; Truong J; Tong J; McCluskey T; Meyer JH; Mizrahi R; Warsh J; Rusjan P; Kennedy JL; Houle S; Kish SJ; Boileau I
    Addict Biol; 2021 Jan; 26(1):e12876. PubMed ID: 32017280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA.
    Kenk M; Selvanathan T; Rao N; Suridjan I; Rusjan P; Remington G; Meyer JH; Wilson AA; Houle S; Mizrahi R
    Schizophr Bull; 2015 Jan; 41(1):85-93. PubMed ID: 25385788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging Microglial Activation in Untreated First-Episode Psychosis: A PET Study With [
    Hafizi S; Tseng HH; Rao N; Selvanathan T; Kenk M; Bazinet RP; Suridjan I; Wilson AA; Meyer JH; Remington G; Houle S; Rusjan PM; Mizrahi R
    Am J Psychiatry; 2017 Feb; 174(2):118-124. PubMed ID: 27609240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [
    Vignal N; Cisternino S; Rizzo-Padoin N; San C; Hontonnou F; Gelé T; Declèves X; Sarda-Mantel L; Hosten B
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29875332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Interaction Between Neuroinflammation and β-Amyloid in Cognitive Decline in Parkinson's Disease.
    Ghadery C; Koshimori Y; Christopher L; Kim J; Rusjan P; Lang AE; Houle S; Strafella AP
    Mol Neurobiol; 2020 Jan; 57(1):492-501. PubMed ID: 31385228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging Microglial Activation in Individuals at Clinical High Risk for Psychosis: an In Vivo PET Study with [
    Hafizi S; Da Silva T; Gerritsen C; Kiang M; Bagby RM; Prce I; Wilson AA; Houle S; Rusjan PM; Mizrahi R
    Neuropsychopharmacology; 2017 Dec; 42(13):2474-2481. PubMed ID: 28604733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimized Quantification of Translocator Protein Radioligand ¹⁸F-DPA-714 Uptake in the Brain of Genotyped Healthy Volunteers.
    Lavisse S; García-Lorenzo D; Peyronneau MA; Bodini B; Thiriez C; Kuhnast B; Comtat C; Remy P; Stankoff B; Bottlaender M
    J Nucl Med; 2015 Jul; 56(7):1048-54. PubMed ID: 26025960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility study of TSPO quantification with [18F]FEPPA using population-based input function.
    Mabrouk R; Strafella AP; Knezevic D; Ghadery C; Mizrahi R; Gharehgazlou A; Koshimori Y; Houle S; Rusjan P
    PLoS One; 2017; 12(5):e0177785. PubMed ID: 28545084
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Ottoy J; De Picker L; Verhaeghe J; Deleye S; Wyffels L; Kosten L; Sabbe B; Coppens V; Timmers M; van Nueten L; Ceyssens S; Stroobants S; Morrens M; Staelens S
    J Nucl Med; 2018 Aug; 59(8):1267-1274. PubMed ID: 29326362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET imaging of [
    Varnäs K; Cselényi Z; Jucaite A; Halldin C; Svenningsson P; Farde L; Varrone A
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):367-375. PubMed ID: 30270409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of the specific translocator protein signal of 18F-PBR111 in healthy humans: a genetic polymorphism effect on in vivo binding.
    Guo Q; Colasanti A; Owen DR; Onega M; Kamalakaran A; Bennacef I; Matthews PM; Rabiner EA; Turkheimer FE; Gunn RN
    J Nucl Med; 2013 Nov; 54(11):1915-23. PubMed ID: 24071511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic analysis of the translocator protein positron emission tomography ligand [
    Feeney C; Scott G; Raffel J; Roberts S; Coello C; Jolly A; Searle G; Goldstone AP; Brooks DJ; Nicholas RS; Trigg W; Gunn RN; Sharp DJ
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2201-2210. PubMed ID: 27349244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vivo imaging of grey and white matter neuroinflammation in Alzheimer's disease: a positron emission tomography study with a novel radioligand, [18F]-FEPPA.
    Suridjan I; Pollock BG; Verhoeff NP; Voineskos AN; Chow T; Rusjan PM; Lobaugh NJ; Houle S; Mulsant BH; Mizrahi R
    Mol Psychiatry; 2015 Dec; 20(12):1579-87. PubMed ID: 25707397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson's disease.
    Jucaite A; Svenningsson P; Rinne JO; Cselényi Z; Varnäs K; Johnström P; Amini N; Kirjavainen A; Helin S; Minkwitz M; Kugler AR; Posener JA; Budd S; Halldin C; Varrone A; Farde L
    Brain; 2015 Sep; 138(Pt 9):2687-700. PubMed ID: 26137956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astroglial Connexin 43 Deficiency Protects against LPS-Induced Neuroinflammation: A TSPO Brain µPET Study with [
    Vignal N; Boulay AC; San C; Cohen-Salmon M; Rizzo-Padoin N; Sarda-Mantel L; Declèves X; Cisternino S; Hosten B
    Cells; 2020 Feb; 9(2):. PubMed ID: 32046185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.